Company / Current Assets
TEVA PHARMACEUTICAL INDUSTRIES LTD Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$13.9B
FY2025
5-year range
$12.1B / $13.9B
FY2021-FY2025
Trend
+11.1%
vs FY2024
Sector context
#10 of 213
Health Care
What the data says
Among 213 Health Care companies, TEVA PHARMACEUTICAL INDUSTRIES LTD is in the top 5% for current assets. Current Assets has increased for 3 consecutive years, from $12.1B in FY2022 to $13.9B in FY2025.
Based on SEC 10-K filings.
$13.9B in FY2025 with a 5-year CAGR of +1.4%. Top quartile in the Health Care sector.
Improved from $12.5B to $13.9B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +5.0%
- 5-Year CAGR
- +1.4%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 213This company $13.9B Sector average $2.5B
▼
+452.8% above sector average
Key checks
Key Insights
- TEVA PHARMACEUTICAL INDUSTRIES LTD's current assets has grown for 3 consecutive years.
- 5-year CAGR of +1.4%, indicating consistent growth.
- In FY2025, current assets increased 11.1% year-over-year.
- Ranks #10 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.9B | +11.1% |
| FY2024 | $12.6B | +0.5% |
| FY2023 | $12.5B | +3.6% |
| FY2022 | $12.1B | -4.2% |
| FY2021 | $12.6B | -3.3% |
| FY2020 | $13.0B | -3.4% |
| FY2019 | $13.5B | -2.4% |
| FY2018 | $13.8B | -10.3% |
| FY2017 | $15.4B | -10.7% |
| FY2016 | $17.2B | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026